Hungary's Welfare Ministry reports that producer and retail prices ofdrugs rose 12% on average on January 15, says MTI Econews. Unconfirmed reports say talks between drugmakers and distributors may mean an agreement for no further prices rises this year.
The Health Insurance Office has 85.6 billion forint ($521.5 million) to spend on drug price subsidies in 1997, against 81.85 billion forint in 1996. Drug prices rose 35% last year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze